Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Histone Demethylase LSD1 Regulates Kidney Cancer Progression by Modulating Androgen Receptor Activity
Kyoung Hwa Lee, Byung-Chan Kim, Seung‐hwan Jeong, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 6089-6089
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Sex and Gender Differences in Kidney Cancer: Clinical and Experimental Evidence
Anna Julie Peired, Riccardo Campi, Maria Lucia Angelotti, et al.
Cancers (2021) Vol. 13, Iss. 18, pp. 4588-4588
Open Access | Times Cited: 52
Epidemiological Trends of Kidney Cancer Along with Attributable Risk Factors in China from 1990 to 2019 and Its Projections Until 2030: An Analysis of the Global Burden of Disease Study 2019
Qianqian Xu, Tingxiao Zhang, Tong Xia, et al.
Clinical Epidemiology (2023) Vol. Volume 15, pp. 421-433
Open Access | Times Cited: 19
Inflammatory Networks in Renal Cell Carcinoma
Linus Kruk, Medina Mamtimin, Attila Braun, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2212-2212
Open Access | Times Cited: 19
The Role of Epigenetics in the Progression of Clear Cell Renal Cell Carcinoma and the Basis for Future Epigenetic Treatments
J.C. Angulo, Claudia Manini, José I. López, et al.
Cancers (2021) Vol. 13, Iss. 9, pp. 2071-2071
Open Access | Times Cited: 34
Pyrroline-5-Carboxylate Reductase 1: a novel target for sensitizing multiple myeloma cells to bortezomib by inhibition of PRAS40-mediated protein synthesis
Inge Oudaert, Hatice Satilmis, Philip Vlummens, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 24
A Novel Machine Learning 13-Gene Signature: Improving Risk Analysis and Survival Prediction for Clear Cell Renal Cell Carcinoma Patients
Patrick Terrematte, Dhiego Souto Andrade, Josivan Ribeiro Justino, et al.
Cancers (2022) Vol. 14, Iss. 9, pp. 2111-2111
Open Access | Times Cited: 20
Histone demethylase LSD1 promotes castration‐resistant prostate cancer by causing widespread gene expression derangements
Haiying Li, Xiujie Fan, Xiuxiu Fang, et al.
IUBMB Life (2025) Vol. 77, Iss. 3
Open Access
Global, regional, and national burden and trends of kidney cancer associated with high BMI from 1990 to 2021: Findings from the Global Burden of Disease Study 2021
Hong Luo, Hailiang Jing, Houyu Zhao, et al.
PLoS ONE (2025) Vol. 20, Iss. 3, pp. e0320185-e0320185
Open Access
Comprehensive in Vitro Characterization of the LSD1 Small Molecule Inhibitor Class in Oncology
Natalia Sacilotto, Paola Dessanti, Michele MP Lufino, et al.
ACS Pharmacology & Translational Science (2021) Vol. 4, Iss. 6, pp. 1818-1834
Open Access | Times Cited: 27
Nephrotoxicity of perfluorooctane sulfonate (PFOS)—effect on transcription and epigenetic factors
Yi Wen, Faizan Rashid, Zeeshan Fazal, et al.
Current Zoology (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 18
Design and Synthesis of Benzene Homologues Tethered with 1,2,4-Triazole and 1,3,4-Thiadiazole Motifs Revealing Dual MCF-7/HepG2 Cytotoxic Activity with Prominent Selectivity via Histone Demethylase LSD1 Inhibitory Effect
Mosa Alsehli, Ateyatallah Aljuhani, Saleh Ihmaid, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8796-8796
Open Access | Times Cited: 16
How Protein Methylation Regulates Steroid Receptor Function
Lucie Malbeteau, Ha Thuy Pham, Louisane Eve, et al.
Endocrine Reviews (2021) Vol. 43, Iss. 1, pp. 160-197
Open Access | Times Cited: 17
Lathyrol reduces the RCC invasion and incidence of EMT via affecting the expression of AR and SPHK2 in RCC mice
Shengyou Song, Lunwei Tai, Yuqi Xu, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Salt Sensitivity of Blood Pressure and Aldosterone: Interaction Between the Lysine-specific Demethylase 1 Gene, Sex, and Age
Wasita Warachit Parksook, Mahyar Heydarpour, Khadijeh Gholami, et al.
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 107, Iss. 5, pp. 1294-1302
Open Access | Times Cited: 11
Androgen Receptor–Interacting Proteins in Prostate Cancer Development and Therapy Resistance
Zoran Čulig, Martin Puhr
American Journal Of Pathology (2023) Vol. 194, Iss. 3, pp. 324-334
Open Access | Times Cited: 6
Tertiary sulphonamide derivatives as dual acting small molecules that inhibit LSD1 and suppress tubulin polymerisation against liver cancer
Lijuan Ding, Feng Wei, Nanya Wang, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2021) Vol. 36, Iss. 1, pp. 1562-1571
Open Access | Times Cited: 12
Arborinine from Glycosmis parva leaf extract inhibits clear-cell renal cell carcinoma by inhibiting KDM1A/UBE2O signaling
Chenchen Feng, Lingxiao Gong, Jing Wang
Food & Nutrition Research (2022) Vol. 66
Open Access | Times Cited: 8
Web-based nomogram and risk stratification system constructed for predicting the overall survival of older adults with primary kidney cancer after surgical resection
Liming Jiang, Chengcheng Wang, Yuexin Tong, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 13, pp. 11873-11889
Closed Access | Times Cited: 4
Lysine-specific demethylase 1 as a therapeutic cancer target: observations from preclinical study
Jessica D. Johnson, Salvador Alejo, Sridharan Jayamohan, et al.
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 12, pp. 1177-1188
Closed Access | Times Cited: 4
The multifaceted role of post-translational modifications of LSD1 in cellular processes and disease pathogenesis
Yin-Rui Li, Bó Wáng, Yi‐Chao Zheng, et al.
Genes & Diseases (2024) Vol. 12, Iss. 3, pp. 101307-101307
Open Access | Times Cited: 1
The influence of sex hormones on renal cell carcinoma
Michael Ladurner, Andrea Katharina Lindner, Peter Rehder, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access | Times Cited: 1
KDM1A Identified as a Potential Oncogenic Driver and Prognostic Biomarker via Multi-Omics Analysis
Lingyue Li, Yiyu Wang, Yuan Mou, et al.
Canadian Journal of Infectious Diseases and Medical Microbiology (2021) Vol. 2021, pp. 1-18
Open Access | Times Cited: 9
5α-Reductase Inhibitors and Risk of Kidney and Bladder Cancers in Men with Benign Prostatic Hyperplasia: A Population-Based Cohort Study
Niamh Doherty, Chris R. Cardwell, Peter Murchie, et al.
Cancer Epidemiology Biomarkers & Prevention (2023) Vol. 32, Iss. 3, pp. 428-434
Open Access | Times Cited: 3
Lathyrol Reduces the RCC Invasion and Incidence of EMT via Affecting the Expression of AR and SPHK2 in RCC mice
Shengyou Song, Lunwei Tai, Yuqi Xu, et al.
Research Square (Research Square) (2024)
Open Access
Mineralocorticoid receptor and aldosterone: Interaction between NR3C2 genetic variants, sex and age in a mixed cohort
Mahyar Heydarpour, Wasita Warachit Parksook, Luminita H. Pojoga, et al.
The Journal of Clinical Endocrinology & Metabolism (2024)
Open Access
Page 1 - Next Page

Scroll to top